Huihui Ma

Also affiliated with Shanghai Tenth People's Hospital, Columbia University

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myeloma”.

Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myeloma

Blood(2020)10.1182/blood.2020006334

N/A

0.442DataRank · unranked

18 citations

Jing Fu, Jun Yang, Huihui Ma, Divaya Bhutani, Markus Y. Mapara +3 more

GCK inhibition enhances iberdomide antimyeloma effects by promoting IKZF1 degradation via a CRBN-independent mechanism

Blood Neoplasia(2025)10.1016/j.bneo.2025.100130

N/A

0.104DataRank · unranked

1 citations

Josefine Krüger, Guifen Liu, Huihui Ma, Michael Sang Hughes, Rajshekhar Chakraborty +6 more

IFN-γR/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graft-versus-host disease

Journal of Clinical Investigation(2022)10.1172/jci125986

N/A

0DataRank · unranked

18 citations

Huihui Ma, Liangsong Song, Hui Wang, Lily Wang, Shirong Li +8 more

The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease

Nature Communications(2023)10.1038/s41467-023-39769-8

N/A

0DataRank · unranked

23 citations

Shirong Li, Huihui Ma, Jun Yang, Gabriel M. Pagnotti, Lewis M. Brown +4 more